Novel coronavirus recombinant antigen coating solution and pretreatment method and application thereof and product

A coronavirus and recombinant antigen technology, applied in the biological field, can solve the problems of high cost of time, manpower and resources, and achieve the effect of improving sensitivity and specificity, and improving stability

Active Publication Date: 2020-05-08
ZHUHAI LIVZON DIAGNOSTICS
View PDF7 Cites 16 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0008] Existing detection reagents for the detection of novel coronavirus antibodies directly use recombinant antigens for coating. In order to improve the sensitivity and accuracy of detection, the curre

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Novel coronavirus recombinant antigen coating solution and pretreatment method and application thereof and product
  • Novel coronavirus recombinant antigen coating solution and pretreatment method and application thereof and product
  • Novel coronavirus recombinant antigen coating solution and pretreatment method and application thereof and product

Examples

Experimental program
Comparison scheme
Effect test
No Example Login to view more

PUM

No PUM Login to view more

Abstract

The invention relates to the technical field of biology, and particularly provides a novel coronavirus recombinant antigen coating solution, a pretreatment method, application and a product. The coronavirus recombinant antigen coating solution is composed of a PBS buffer solution, acidic amino acid, BSA, mannitol, trehalose, Proclin300 and water, the stability of the novel coronavirus recombinantantigen in the detection reagent can be effectively improved through mutual coordination and cooperation of all the components, and the sensitivity and specificity of the novel coronavirus antibody detection reagent are effectively improved. Besides, the inventor treats the novel coronavirus recombinant antigen by utilizing DNA hydrolase, randomly decomposes a host DNA fragment in the novel coronavirus recombinant antigen to generate oligonucleotide, eliminates the interference of the DNA fragment on a later antigen detection antibody, and has a remarkable result.

Description

technical field [0001] The present invention relates to the field of biotechnology, in particular, to a coating solution, pretreatment method, application and product of a novel coronavirus recombinant antigen. Background technique [0002] Beginning in December 2019, a novel coronavirus pneumonia (COVID-19), an acute respiratory infectious disease caused by a new type of coronavirus (SARS-CoV-2) infection, emerged. [0003] Coronaviruses are non-segmented single-stranded positive-sense RNA viruses belonging to the Orthocoronavirinae subfamily of the Coronaviridae family of the order Nidovirales. There are 6 coronaviruses known to infect humans, including 229E and NL63 of the genus α, OC43 and HKU1 of the genus β, Middle East respiratory syndrome-associated coronavirus (MERSr-CoV) and severe acute respiratory syndrome-associated coronavirus (SARSr-CoV). CoV). The coronavirus that emerged this time is a new type of coronavirus belonging to the genus Beta. Coronaviruses are...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): G01N33/68G01N33/569G01N33/531G01N33/558
CPCG01N33/531G01N33/558G01N33/56983G01N33/6854G01N2333/165G01N2469/20
Inventor 胡大银赖晓宁况承钰张荣华曾敏霞朱越谭
Owner ZHUHAI LIVZON DIAGNOSTICS
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products